Stephen L. Rawlings

Array ( [id] => 6356661 [patent_doc_number] => 20020058028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'METHOD OF IN SITU DIAGNOSIS BY SPECTROSCOPIC ANALYSIS OF BIOLOGICAL STAIN COMPOSITIONS' [patent_app_type] => new [patent_app_number] => 09/306662 [patent_app_country] => US [patent_app_date] => 1999-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7046 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058028.pdf [firstpage_image] =>[orig_patent_app_number] => 09306662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1030975 [patent_doc_number] => 06878526 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-12 [patent_title] => 'Treating cancer' [patent_app_type] => utility [patent_app_number] => 09/622577 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5676 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878526.pdf [firstpage_image] =>[orig_patent_app_number] => 09622577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884990 [patent_doc_number] => 07351810 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-01 [patent_title] => 'Polypeptides, polynucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/581651 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 22979 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351810.pdf [firstpage_image] =>[orig_patent_app_number] => 09581651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 528200 [patent_doc_number] => 07183400 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-27 [patent_title] => 'Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes' [patent_app_type] => utility [patent_app_number] => 09/367496 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 35 [patent_no_of_words] => 12160 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183400.pdf [firstpage_image] =>[orig_patent_app_number] => 09367496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021329 [patent_doc_number] => 06887705 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs)' [patent_app_type] => utility [patent_app_number] => 09/068377 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 19 [patent_no_of_words] => 34412 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887705.pdf [firstpage_image] =>[orig_patent_app_number] => 09068377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380514 [patent_doc_number] => 06559285 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Nucleotide and protein sequences of lats genes and methods based thereon' [patent_app_type] => B1 [patent_app_number] => 08/939106 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 51 [patent_no_of_words] => 52289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559285.pdf [firstpage_image] =>[orig_patent_app_number] => 08939106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6773809 [patent_doc_number] => 20030017147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'COMPOSITION AND METHOD FOR ENHANCING FIBRINOLYSIS' [patent_app_type] => new [patent_app_number] => 08/934000 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23572 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017147.pdf [firstpage_image] =>[orig_patent_app_number] => 08934000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 755128 [patent_doc_number] => 07019112 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-28 [patent_title] => 'Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor' [patent_app_type] => utility [patent_app_number] => 08/816454 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 41 [patent_no_of_words] => 33839 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019112.pdf [firstpage_image] =>[orig_patent_app_number] => 08816454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679446 [patent_doc_number] => 07083943 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-01 [patent_title] => 'Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 08/836455 [patent_app_country] => US [patent_app_date] => 1996-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 38 [patent_no_of_words] => 48298 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083943.pdf [firstpage_image] =>[orig_patent_app_number] => 08836455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963432 [patent_doc_number] => 06949244 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-27 [patent_title] => 'Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 08/766350 [patent_app_country] => US [patent_app_date] => 1996-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 36 [patent_no_of_words] => 48522 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949244.pdf [firstpage_image] =>[orig_patent_app_number] => 08766350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551625 [patent_doc_number] => 06399744 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'TCF mutant' [patent_app_type] => B1 [patent_app_number] => 08/700519 [patent_app_country] => US [patent_app_date] => 1996-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5935 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399744.pdf [firstpage_image] =>[orig_patent_app_number] => 08700519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4556036 [patent_doc_number] => 07838216 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-11-23 [patent_title] => 'Human gene related to but distinct from EGF receptor gene' [patent_app_type] => utility [patent_app_number] => 07/110791 [patent_app_country] => US [patent_app_date] => 1987-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9980 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838216.pdf [firstpage_image] =>[orig_patent_app_number] => 07110791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12707035 [patent_doc_number] => 20180127511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same [patent_app_type] => utility [patent_app_number] => 15/784967 [patent_app_country] => US [patent_app_date] => 1918-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24713 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784967 [rel_patent_id] =>[rel_patent_doc_number] =>)